Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs
Stephen E. Wolverton; Kathleen Remlinger (Profiled Author: Stephen E. Wolverton)
Dermatologic Clinics. 2007;25(2):195-205.Abstract
Hepatic and hematologic toxicity are among the most fearful adverse effects that occasionally occur as a result of systemic drugs in the dermatologist's therapeutic armamentarium. Drugs of greatest interest concerning hepatic toxicity include methotrexate, azathioprine, dapsone, and acitretin. Somewhat overlapping are drugs that have important hematologic toxicities, including methotrexate, azathioprine, dapsone, sulfonamides, cyclophosphamide, and chlorambucil. Laboratory tests most commonly used include (1) hepatic monitoring: transaminases (AST/SGOT and ALT/SGPT) and the ultrasound-guided liver biopsy, and (2) hematologic monitoring: CBC with diff and platelets along with occasional use of the reticulocyte count. Important principles and specific guidelines for monitoring by drug group are highlighted. © 2007 Elsevier Inc. All rights reserved.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
S.E. WolvertonJournal of the American Academy of Dermatology. 1992;26(5 I):661-679.
Michael O'Connor; Richard S. Mangus; A. Joseph Tector; Jonathan A. Fridell; Rodrigo M. ViannaJournal of Pediatric Surgery. 2011;46(6):1057-1062.
S. Vadhan-Raj; A. Al-Katib; R. Bhalla; L. Pelus; C.F. Nathan; S.A. Sherwin; H.F. Oettgen; S.E. KrownJournal of Clinical Oncology. 1986;4(2):137-146.
Appears in this Document